
Mechanistic aspects of the formation of α-dystroglycan and therapeutic research for the treatment of α-dystroglycanopathy: A review
Keywords: α-DG; Glycosyltransferase; O-Mannose glycan; Ribitol 5-phosphate; Antisense therapy; Fukuyama congenital muscular dystrophy; α-DG; alpha-dystroglycan; FCMD; Fukuyama type congenital muscular dystrophy; MEB; muscle eye brain disease; WWS; Walker Warburg